ACM-Pivotal Shares Global Central Lab Expertise at Partnerships with Central, ECG & Imaging Labs Show.Multiple Executives Present on Panels Highlighting the Role of Central Labs ACM-Pivotal:
WHO: ACM-Pivotal sets itself apart by its single focus on providing
global central lab services with an inherently flexible
approach. This allows the organization to offer an array of
global capabilities with the personal attention and unique
customization required to keep clinical trials on schedule.
Peter Napier, director, Business Development, has 20 years
experience as a biomedical scientist, and has worked in
contract research for the pharmaceutical industry for more than
12 years. Napier's range of experience spans all phases of
clinical development. As head of the European business
development team, Peter has been responsible for a rapidly
growing global client base.
Kathleen Murray, executive director, Global Operations and
Strategic Development, has spent more than 25 years in the
clinical laboratory with experience in all areas of general
laboratory testing. Murray has been aligned with the clinical
trials central laboratory division, ACM-Pivotal since 1997. A
primary responsibility is to expand the central lab's global
presence to India and other regions of interest while ensuring
data harmonization and standardization of process.
Elena Logan, VP, Clinical Trials, has 19 years experience in
the clinical research industry. Logan's experience is comprised
of project management for a major pharmaceutical company,
clinical operations and business development in the CRO
industry. In her present role, Elena is responsible for overall
growth and business strategy
WHAT: "Getting the Small Pharmaceutical Perspective on Leveraging the
Value of Lab Relationships." Peter Napier will present his
experience on working with smaller pharmas and discuss the need
for labs to understand their typical internal processes for a
successful partnership. He will be joined by representatives
from King Pharmaceuticals and Cerexa.
WHEN: Friday, Jan. 19 at 11:00 a.m.
"Effective and Efficient Outsourcing and Operational Process
Strategies for Working with Smaller Pharmaceutical Companies."
Kathy Murray will focus on how to leverage the expertise of
global central labs and develop true partnerships to better
manage projects and improve external efficiencies. She will
provide tips on gaining process efficiencies, setting
expectations, and improving IT support. Other panelists
include representatives from Coley Pharmaceutical Group and
Celtic Pharma.
WHEN: Friday, Jan. 19 at 2:15 p.m.
"Effective Use of Mid-Sized Central Labs for Global Studies."
Elena Logan will present industry-leading best practices when
partnering with a global central lab. The focus will be on
global clinical trials, which require understanding of local
logistics and standards.
WHEN: Friday, Jan. 19 at 3:00 p.m.
WHERE: Disneyland Hotel & Resort - Anaheim, CA. ACM-Pivotal will be
exhibiting at Booth #65.
For information on the conference, please visit
http://www.iirusa.com/centrallab
About ACM-Pivotal ACM-Pivotal is the global central laboratory with an inherently flexible approach and a focus on precision to keep clinical research studies on schedule. The organization sets itself apart by its single focus on global central lab services. ACM-Pivotal is defining the industry standard by continually con·tin·u·al adj. 1. Recurring regularly or frequently: the continual need to pay the mortgage. 2. developing customer-centric processes and services. With a staff of 360 laboratory science and clinical research experts, ACM-Pivotal's global operations Global Operations is a first-person shooter computer game developed by Barking Dog Studios and published by both Crave Entertainment and Electronic Arts. It was released in March of 2002, following its public multiplayer beta version which contained only the Quebec map. extend to more than 60 countries and offer a broad and customized menu of safety and specialty A contract under seal. A specialty is a written document that has been sealed and delivered and is given as security for the payment of a specifically indicated debt. services for clinical trials. The organization's research team performs 12 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including Pathology pathology, study of the cause of disease and the modifications in cellular function and changes in cellular structure produced in any cell, organ, or part of the body by disease. , Microbiology microbiology: see biology. microbiology Scientific study of microorganisms, a diverse group of simple life-forms including protozoans, algae, molds, bacteria, and viruses. and Pharmacogenomics Pharmacogenomics is the branch of pharmacology which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity. . For more information, visit www.acm-pivotal.com. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion